Literature DB >> 35571681

Autoimmune Retinopathy, Testing, and Its Controversies.

Luiz Roisman1,2, Julia Dutra Rossetto1,3, Raquel Goldhardt4.   

Abstract

Purpose of review: The purpose of this revision is to sumarize the most important clinical features of the autoimune retinopathies (AIRs). Recent findings: AIRs are a group of inflammatory conditions affecting the retina characterized by progressive unexplained visual loss, abnormalities and contraction in visual fields, photoreceptor and electroretinographic dysfunction, and the presence of circulating anti-retinal antibodies. The pathogenesis of AIR remains unclear and various antiretinal antibodies have been associated to the disease. The diagnosis of AIR is based on a particular clinical presentation along with the detection of serum antiretinal antibodies. Numerous anti-inflammatory therapeutic alternatives have been described for the treatment of AIR, nevertheless there is no consensus on treatment protocol. Summary: Because of its association with different types of malignant tumors, the early diagnosis, multi-disciplinary approach and prompt treatment should be warranted.

Entities:  

Keywords:  Autoimmune retinopathy; anti-retinal antibodies; cancer-associated retinopathy; melanoma-associated retinopathy

Year:  2021        PMID: 35571681      PMCID: PMC9093165          DOI: 10.1007/s40135-021-00276-y

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  19 in total

1.  Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy.

Authors:  Sepideh Faez; John Loewenstein; Lucia Sobrin
Journal:  JAMA Ophthalmol       Date:  2013-01       Impact factor: 7.389

2.  Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.

Authors:  Grazyna Adamus; Rachel Champaigne; Sufang Yang
Journal:  Clin Immunol       Date:  2019-11-23       Impact factor: 3.969

3.  Hyperautofluorescent ring in autoimmune retinopathy.

Authors:  Luiz H Lima; Jonathan P Greenberg; Vivienne C Greenstein; R Theodore Smith; Juliana M F Sallum; Charles Thirkill; Lawrence A Yannuzzi; Stephen H Tsang
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

4.  Optical coherence tomography findings in autoimmune retinopathy.

Authors:  Azin Abazari; Souha S Allam; Grazyna Adamus; Nicola G Ghazi
Journal:  Am J Ophthalmol       Date:  2012-01-14       Impact factor: 5.258

Review 5.  Autoimmune retinopathy.

Authors:  Landon Grange; Monica Dalal; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

Review 6.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

7.  Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Authors:  Austin R Fox; Lynn K Gordon; John R Heckenlively; Janet L Davis; Debra A Goldstein; Careen Y Lowder; Robert B Nussenblatt; Nicholas J Butler; Monica Dalal; Thiran Jayasundera; Wendy M Smith; Richard W Lee; Grazyna Adamus; Chi-Chao Chan; John J Hooks; Catherine W Morgans; Barbara Detrick; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2016-05-20       Impact factor: 5.258

Review 8.  Autoimmune retinopathy and antiretinal antibodies: a review.

Authors:  Dilraj S Grewal; Gerald A Fishman; Lee M Jampol
Journal:  Retina       Date:  2014-05       Impact factor: 4.256

9.  Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.

Authors:  Grazyna Adamus; Gaoying Ren; Richard G Weleber
Journal:  BMC Ophthalmol       Date:  2004-06-04       Impact factor: 2.209

Review 10.  Autoimmune retinopathy: A Review.

Authors:  Aristófanes Mendonça Canamary; Walter Yukihiko Takahashi; Juliana Maria Ferraz Sallum
Journal:  Int J Retina Vitreous       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.